Circulating B-Vitamins and Smoking Habits Are Associated with Serum Polyunsaturated Fatty Acids in Patients with Suspected Coronary Heart Disease: A Cross-Sectional Study

The long-chain polyunsaturated fatty acids are considered to be of major health importance, and recent studies indicate that their endogenous metabolism is influenced by B-vitamin status and smoking habits. We investigated the associations of circulating B-vitamins and smoking habits with serum polyunsaturated fatty acids among 1,366 patients who underwent coronary angiography due to suspected coronary heart disease at Haukeland University Hospital, Norway. Of these, 52% provided information on dietary habits by a food frequency questionnaire. Associations were assessed using partial correlation (Spearman’s rho). In the total population, the concentrations of most circulating B-vitamins were positively associated with serum n-3 polyunsaturated fatty acids, but negatively with serum n-6 polyunsaturated fatty acids. However, the associations between B-vitamins and polyunsaturated fatty acids tended to be weaker in smokers. This could not be solely explained by differences in dietary intake. Furthermore, plasma cotinine, a marker of recent nicotine exposure, showed a negative relationship with serum n-3 polyunsaturated fatty acids, but a positive relationship with serum n-6 polyunsaturated fatty acids. In conclusion, circulating B-vitamins are, in contrast to plasma cotinine, generally positively associated with serum n-3 polyunsaturated fatty acids and negatively with serum n-6 polyunsaturated fatty acids in patients with suspected coronary heart disease. Further studies should investigate whether B-vitamin status and smoking habits may modify the clinical effects of polyunsaturated fatty acid intake.

[1]  Brian A. King,et al.  Validation of self-reported smokeless tobacco use by measurement of serum cotinine concentration among US adults. , 2014, American journal of epidemiology.

[2]  J. Hiltunen,et al.  Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study , 2013, BMC Medicine.

[3]  T. Mizoue,et al.  Polyunsaturated fatty acids in serum and homocysteine concentrations in Japanese men and women: a cross-sectional study , 2013, Nutrition & Metabolism.

[4]  M. Roncaglioni,et al.  n-3 fatty acids in patients with multiple cardiovascular risk factors. , 2013, The New England journal of medicine.

[5]  D. Vance.  Physiological roles of phosphatidylethanolamine N-methyltransferase. , 2013, Biochimica et biophysica acta.

[6]  J. Gregory,et al.  Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells. , 2013, American journal of physiology. Endocrinology and metabolism.

[7]  J. Gregory,et al.  Marginal vitamin B-6 deficiency decreases plasma (n-3) and (n-6) PUFA concentrations in healthy men and women. , 2012, The Journal of nutrition.

[8]  E. Ntzani,et al.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.

[9]  J. Geleijnse,et al.  Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. , 2012, European heart journal.

[10]  A. Viste,et al.  Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat , 2012, Lipids in Health and Disease.

[11]  R. Wurtman,et al.  Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats , 2012, Nutrition & Metabolism.

[12]  M. Nobuyoshi,et al.  Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[13]  P. Amouyel,et al.  Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios[S] , 2010, Journal of Lipid Research.

[14]  S. Vollset,et al.  Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. , 2010, The American journal of clinical nutrition.

[15]  S. Vollset,et al.  Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. , 2010, Clinical Chemistry.

[16]  P. Ueland,et al.  Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[17]  S. Innis,et al.  Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-gamma-linolenic and eicosapentaenoic acid in plasma of adult men. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[18]  W. Harris,et al.  Clinical Investigation : Determinants of Blood Cell Omega-3 Fatty Acid Content , 2008 .

[19]  S. Vollset,et al.  Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated , 2008 .

[20]  W. Harris.  The omega-3 index as a risk factor for coronary heart disease. , 2008, The American journal of clinical nutrition.

[21]  A. Jamurtas,et al.  Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study , 2008, Arthritis research & therapy.

[22]  P. Ueland,et al.  Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry , 2007, Clinical chemistry and laboratory medicine.

[23]  C. Galli,et al.  Effects of Cigarette Smoke on Cell Viability, Linoleic Acid Metabolism and Cholesterol Synthesis, in THP−1 Cells , 2007, Lipids.

[24]  S. Vollset,et al.  Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. , 2007, The American journal of clinical nutrition.

[25]  S. Vollset,et al.  Dietary predictors of plasma total homocysteine in the Hordaland Homocysteine Study , 2007, British Journal of Nutrition.

[26]  U. Das,et al.  Essential fatty acids: biochemistry, physiology and pathology , 2006, Biotechnology journal.

[27]  M. Dusinska,et al.  Polyunsaturated Fatty Acid Plasma Content in Groups of General Population with LowVitamin B6 or Low Iron Serum Levels , 2004, Annals of Nutrition and Metabolism.

[28]  S. Watkins,et al.  Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. , 2003, The Journal of nutrition.

[29]  R. Rosenson.  Rosuvastatin: a new inhibitor of HMG-CoA reductase for the treatment of dyslipidemia , 2003, Expert review of cardiovascular therapy.

[30]  K. Furie,et al.  Low Vitamin B6 but Not Homocyst(e)ine Is Associated With Increased Risk of Stroke and Transient Ischemic Attack in the Era of Folic Acid Grain Fortification , 2003, Stroke.

[31]  P. Couvreur,et al.  Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  R. Head,et al.  Longchain n-3 polyunsaturated fatty acids and blood vessel function. , 2001, Cardiovascular research.

[33]  T. Mukherjee,et al.  Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. , 2001, Free radical biology & medicine.

[34]  Ming Li,et al.  Vitamin B6 (Pyridoxine) and Its Derivatives Are Efficient Singlet Oxygen Quenchers and Potential Fungal Antioxidants , 2000, Photochemistry and photobiology.

[35]  Ming Li,et al.  Symposium-in-Print Vitamin B6 (Pyridoxine) and Its Derivatives Are Efficient Singlet Oxygen Quenchers and Potential Fungal Antioxidants , 2000 .

[36]  Michael J. Thomas,et al.  Molecular Distinction of Phosphatidylcholine Synthesis between the CDP-Choline Pathway and Phosphatidylethanolamine Methylation Pathway* , 1999, The Journal of Biological Chemistry.

[37]  A. Lorenzini,et al.  Dual influence of aging and vitamin B6 deficiency on delta-6-desaturation of essential fatty acids in rat liver microsomes. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[38]  D. Hunninghake,et al.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) , 1998, The American journal of cardiology.

[39]  J. Witteman,et al.  Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. , 1998, Circulation.

[40]  J. Manson,et al.  Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. , 1998, JAMA.

[41]  W C Willett,et al.  Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. , 1996, American journal of epidemiology.

[42]  J. Driskell,et al.  Erythrocyte and plasma B-6 vitamer concentrations of long-term tobacco smokers, chewers, and nonusers. , 1995, The American journal of clinical nutrition.

[43]  Q. She,et al.  Alteration in the phosphatidylcholine biosynthesis of rat liver microsomes caused by vitamin B6 deficiency. , 1995, Bioscience, biotechnology, and biochemistry.

[44]  Q. She,et al.  Effect of Vitamin B6 Deficiency on Linoleic Acid Desaturation in the Arachidonic Acid Biosynthesis of Rat Liver Microsomes , 1994 .

[45]  T. Toyosaki,et al.  Antioxidant effect of riboflavin in enzymic lipid peroxidation , 1992 .

[46]  B. Kelleher,et al.  Microbiological assay for vitamin B12 performed in 96-well microtitre plates. , 1991, Journal of clinical pathology.

[47]  S. Coburn.  Location and Turnover of Vitamin B6 Pools and Vitamin B6 Requirements of Humans a , 1990, Annals of the New York Academy of Sciences.

[48]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[49]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[50]  H. Tunstall-Pedoe,et al.  Comparison of tests used to distinguish smokers from nonsmokers. , 1987, American journal of public health.

[51]  R. Read.  [Systemic effects of smoking]. , 1984, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[52]  B. Turner.  Nordic Council , 1968, International and Comparative Law Quarterly.

[53]  S. Ghezzi,et al.  The in vitro effects of cigarette smoke on fatty acid metabolism are partially counteracted by simvastatin. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[54]  Georgia Salanti,et al.  Homocysteine lowering interventions for preventing cardiovascular events. , 2009, The Cochrane database of systematic reviews.

[55]  Duo Li,et al.  A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects , 2006, Lipids.

[56]  J. Bertrandt,et al.  Content of polyunsaturated fatty acids (PUFAs) in serum and liver of rats fed restricted diets supplemented with vitamins B2, B6 and folic acid , 2004, BioFactors.

[57]  J. Scott,et al.  Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. , 1997, Methods in enzymology.